MELISSA J CALDER

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease PAOLI, PA NPI 1366735367

General Payments — all program years on this page

$5,607.86

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 249
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $491.99 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $491.9922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $769.2641
2019 $1,343.2468
2020 $622.1030
2021 $796.9134
2022 $838.5029
2023 $745.8625
2024 $491.9922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092327074 Boston Scientific Corporation $28.87 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092327076 Boston Scientific Corporation $29.89 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104245449 AstraZeneca Pharmaceuticals LP $15.29 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104279493 AstraZeneca Pharmaceuticals LP $18.55 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105566788 AstraZeneca Pharmaceuticals LP $24.58 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105786956 AstraZeneca Pharmaceuticals LP $24.34 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110765203 Eisai Inc. $18.09 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018100 Regeneron Healthcare Solutions, Inc. $35.49 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115476224 Amgen Inc. $32.11 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115476232 Amgen Inc. $29.16 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115476238 Amgen Inc. $14.75 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116182892 GlaxoSmithKline, LLC. $16.28 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116233566 GlaxoSmithKline, LLC. $14.49 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116455903 GlaxoSmithKline, LLC. $22.55 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116517156 GlaxoSmithKline, LLC. $22.45 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116601165 GlaxoSmithKline, LLC. $21.85 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131214621 PFIZER INC. $19.56 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137882583 Electromed, Inc. $15.88 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139794754 GENZYME CORPORATION $28.13 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146897576 Philips North America LLC $14.51 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147328592 Mylan Specialty L.P. $21.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147350293 Mylan Specialty L.P. $24.04 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.